Spinal Tech

The FDA issued 13 orthopedic-related 510(k) clearances in September, according to a report by the FDA.

Smith & Nephew Biologics & Spine has launched the TRUCATH◊ Spinal Injection System, a new system for performing transforaminal epidural injections, according to a Smith & Nephew news release.

Sen. Charles Grassley (R-Iowa) sent a letter to officials at the University of Minnesota, questioning statements made by David Polly, MD, a spine surgeon at the university, regarding his 2006 research using Medtronic's Infuse, a bone growth product, according to…

Zimmer Holdings has settled its lawsuit against Smith & Nephew Inc. over a patent for a bone screw to treat bone fractures, according to a report by MassDevice.

At Medtronic's annual shareholder meeting, CEO Bill Hawkins defended the company's payments to and collaborations with physicians, saying the partnerships advance medical technology, according to a report in the Star Tribune.

An initial cohort of 15 patients has reached the two-year mark in an ongoing clinical trial for a posterior dynamic stabilization device designed to support an injured or degenerative spine without eliminating motion, according a release from the maker, Applied…

Memphis, Tenn.-based Smith & Nephew's revenues for the second quarter were $926 million, down 8 percent from $1 billion in 2008, according to a report in the Memphis Business Journal.

David Polly, MD, a spine surgeon at the University of Minnesota, is under scrutiny after he failed to disclose payments he received from Medtronic for consulting services in May 2006 testimony in front of a Senate committee, asking for government…

Zimmer Holdings second-quarter sales revenue has decreased 5.5 percent from second-quarter 2008, according to a Zimmer news release.

Stryker's second-quarter 2009 sales revenue has decreased 4.6 percent from second-quarter 2008 due to losses in currency value and sales revenue, according to a Stryker news release.